手把手搭一套前端监控采集 SDK

Artificial intelligence (AI) has shown promise in musculoskeletal imaging, yet the diagnostic contribution of large language models (LLMs) remains unclear. Prompt engineering may critically shape performance.

Cannabidiol (CBD), a non-psychoactive phytocannabinoid, attributed to its therapeutic benefits and positive safety profile is being studied for its potential to treat various medical conditions. The low oral bioavailability and significant first-pass metabolism present pharmacokinetic (PK) challenges. The present study aimed to evaluate the PK profile of a novel nanodispersible CBD oral solution (150 mg/mL) under fasting and fed conditions in healthy male subjects.

This white paper introduces aoip.ai, a groundbreaking open-source SDK incorporating peer-to-peer technology and advanced AI integration to transform VoIP and IoT applications. It addresses key market challenges by enhancing data security, elevating communication quality, and providing greater flexibility for developers and users. Developed in collaboration with Carnegie Mellon University, aoip.ai sets a new standard for decentralized and democratized communication solutions.

Clinical studies struggle to locate the right patients, in part because many remain undiagnosed or lack relevant labels. We develop and prospectively test a physiology-based patient representation ("Bioprofile") to evaluate whether it can reduce the number of individuals who must be screened and enable more precise targeting of candidates for steatotic liver disease studies.